COVID-19 outcomes for patients on immunosuppressive drugs on par with non- immunosuppressed patients

https://www.eurekalert.org/pub_releases/2021-01/jhub-sb010721.php

 

News Release 7-Jan-2021
Johns Hopkins University Bloomberg School of Public Health

 

People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health.


•••••